Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-Arinate FDC vs Coartem in Uncomplicated P. falciparum Malaria
NCT00484900Phase 3Completed
- Sponsor
- Dafra Pharma
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of artesunate + sulfamethoxypyrazine + pyrimethamine in Plasmodium falciparum malaria, sponsored by Dafra Pharma. Started May 2006; status: completed.
02
Drugs
artesunate + sulfamethoxypyrazine + pyrimethamine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00484900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484900.